The PI3K/Akt/mTOR signaling pathway in gastric cancer; from oncogenic variations to the possibilities for pharmacologic interventions

ABS Khorasani, A Pourbagheri-Sigaroodi… - European Journal of …, 2021 - Elsevier
Genetic and epigenetic alterations have been under concentrated investigations for many
years in order to unearth the molecules regulating human cancer pathogenesis. However …

The PI3K/Akt/mTORC signaling axis in head and neck squamous cell carcinoma: Possibilities for therapeutic interventions either as single agents or in combination …

N Akbari Dilmaghani, A Safaroghli‐Azar… - IUBMB …, 2021 - Wiley Online Library
The latest advances in the sequencing methods in head and neck squamous cell carcinoma
(HNSCC) tissues have revolutionized our understanding of the disease by taking off the veil …

Suppression of c‐Myc using 10058‐F4 exerts caspase‐3‐dependent apoptosis and intensifies the antileukemic effect of vincristine in pre‐B acute lymphoblastic …

N Sheikh‐Zeineddini, D Bashash… - Journal of cellular …, 2019 - Wiley Online Library
Despite an old history behind the identification of the leading role of c‐Myc in
leukemogenesis, the road to constructing a therapeutic perspective for this molecule in …

The influence of PI3K inhibition on the radiotherapy response of head and neck cancer cells

M Glorieux, R Dok, S Nuyts - Scientific Reports, 2020 - nature.com
Radiotherapy has a central role in the treatment of head and neck squamous cell carcinoma
(HNSCC). Activation of the PI3K/AKT/mTOR pathway can decrease the efficiency of …

Targeting the phosphatidylinositol 3‐kinase/Akt/mechanistic target of rapamycin signaling pathway in B‐lineage acute lymphoblastic leukemia: An update

C Simioni, AM Martelli, G Zauli, M Vitale… - Journal of Cellular …, 2018 - Wiley Online Library
Despite considerable progress in treatment protocols, B‐lineage acute lymphoblastic
leukemia (B‐ALL) displays a poor prognosis in about 15–20% of pediatric cases and about …

Small molecule inhibitor of c-Myc 10058-F4 inhibits proliferation and induces apoptosis in acute leukemia cells, irrespective of PTEN status

D Bashash, M Sayyadi, A Safaroghli-Azar… - The international journal …, 2019 - Elsevier
Based on the frequent over-expression of c-Myc in hematologic malignancies and its crucial
role in the regulation of diverse oncogenic pathways involved in leukomogenesis, intense …

The PI3K signaling pathway; from normal lymphopoiesis to lymphoid malignancies

B Kashani, Z Zandi… - Expert Review of …, 2024 - Taylor & Francis
Introduction As a vital mechanism of survival, lymphopoiesis requires the collaboration of
different signaling molecules to orchestrate each step of cell development and maturation …

Novel synthetic drugs currently in clinical development for chronic lymphocytic leukemia

P Robak, T Robak - Expert Opinion on Investigational Drugs, 2017 - Taylor & Francis
Introduction: Over the last few years, several new synthetic drugs, particularly Bruton's
tyrosine kinase (BTK), phosphatidylinositol 3-kinase (PI3K) and BCL-2 inhibitors have been …

Research update on the anticancer effects of buparlisib

J Xing, J Yang, Y Gu, J Yi - Oncology Letters, 2021 - spandidos-publications.com
Buparlisib is a highly efficient and selective PI3K inhibitor and a member of the 2, 6‑
dimorpholinopyrimidine‑derived family of compounds. It selectively inhibits four isomers of …

Anticancer effect of pan-PI3K inhibitor on multiple myeloma cells: Shedding new light on the mechanisms involved in BKM120 resistance

A Safaroghli-Azar, D Bashash, A Kazemi… - European journal of …, 2019 - Elsevier
The correlation between the Phosphoinositide 3-kinase (PI3K) axis and crucial mechanisms
involved in the maintenance of the neoplastic nature of multiple myeloma (MM) has recently …